LKT Labs, 1032568-63-0, NEW! Life Science

Sort
View
Show
  • LKT Labs

    BAY80-6946 is an inhibitor of p110a PI3K that exhibits anticancer chemotherapeutic activity. BAY80-6946 is currently in clinical trials and shows some benefit in the treatment of pancreatic cancer. In cellular and animal models of multiple myeloma, BAY80-6946 inhibits cell cycle progression,…